Drug
Dose 1 OF Qls1410
Dose 1 OF Qls1410: highest development phase Phase 2, developed by Qilu Pharmaceutical Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Qilu Pharmaceutical Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dose 1 of QLS1410 NCT07927556 | Phase 2 | Uncontrolled Hypertension |
Latest
No recent events.
Follow Dose 1 OF Qls1410 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.